about
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritisA genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides.What is the prevalence of MRI-detected inflammation and erosions in small joints in the general population? A collation and analysis of published data.Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis.The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor?Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts.The inflammatory disease-associated variants in IL12B and IL23R are not associated with rheumatoid arthritisA genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritisAutoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.Association of valine and leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated protein antibodies.Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritisCan anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?Possibilities for preventive treatment in rheumatoid arthritis? Lessons from experimental animal models of arthritis: a systematic literature review and meta-analysis.An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activityContribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis.Protection against rheumatoid arthritis by HLA: nature and nurture.Longitudinal IP-10 Serum Levels Are Associated with the Course of Disease Activity and Remission in Patients with Rheumatoid Arthritis.Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies.Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.Bone mineral density loss in clinically suspect arthralgia is associated with subclinical inflammation and progression to clinical arthritis.The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles.Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles.The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis.Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis.Effects of wearing high heels on the forefoot: an MRI evaluation.Evaluation of the contribution of cumulative levels of inflammation to the variance in joint destruction in rheumatoid arthritis.Patients with early arthritis consume less alcohol than controls, regardless of the type of arthritis.The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis.Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study.Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort.Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art.Evaluation of the joint distribution at disease presentation of patients with rheumatoid arthritis: a large study across continents.Preventing progression from arthralgia to arthritis: targeting the right patients.
P50
Q24812184-6433FE0F-EE1D-4619-90C0-E27D721F18B2Q29417125-2C39E54A-219C-49D0-82A6-97009E8F071CQ31012258-8C2E9B80-396D-437E-B341-6A73BFA6E0B5Q33722090-FFBEC97C-BBA9-4914-B2C1-B0A4B5F39DC1Q33750031-FCC3AF0B-E597-4B2A-BD49-09EA48AF8483Q33888275-EA468222-8B6B-464F-8D1F-4C6743A2A0B8Q34746646-5E06BC7D-68CC-4268-9B62-DE15412D91D9Q34781620-C7402ACB-BC41-42B0-B531-2E08E4D66991Q35053861-6B843886-DBA2-4D5B-AA98-2E05EDA108EBQ35408694-EE5AD9BB-E74D-4439-8CCF-A78495078819Q35563220-0C504939-4A76-4880-B6BE-D96A89C893EAQ35752661-B6AD76D3-96F1-4E7E-A8B4-C02101845775Q35840850-1A849E68-92DB-4BE7-90DC-F5462644CD80Q36092234-F1CB73D3-ADC9-48C5-9102-9F53A1D9AAC7Q36127049-4B298610-FF0A-4C51-BEA9-F6B1CE3341ABQ36251297-B65ECE7E-5EF5-4C08-86A6-2469DBA48D22Q36428250-40DDF1F9-392C-4493-8870-F4121A7C8ADDQ37329728-5FDA0C42-CC26-4C05-96E6-250B52796D1AQ37331085-433B2845-0408-4A38-8101-E0C0BFFA6AC9Q38737488-2A9C6CC7-381B-4B15-B48E-3BB951C5332AQ39139958-973C6190-CBE8-4CA3-B807-68855F4E68F5Q39824299-AA9CF2F5-E568-4C80-BF27-EF9100F919A3Q40117130-AFF436B1-A29D-48DD-8165-B52CE4A65EDCQ40160018-8F3B2A20-37A9-43E2-AAA2-E0C7B6BE50E3Q40476039-B701B396-8896-4308-9955-506257B00F32Q41431357-CCE55660-4BF0-4D39-9EAA-AC6E1AFB4246Q42616461-3CC84378-0FAA-49ED-8C04-591CDCBC9D12Q42630339-6C71B78F-EF6E-4FA0-A0C7-D30E24B27352Q42638404-4F7AA9C2-4BB3-4503-8E25-775184FFA254Q43158822-DD61A11F-A1A1-4EC8-91BB-413AB3B59D24Q44118268-C170F6F6-34FE-4C64-85BE-E6A4F49DDC38Q44224416-466252F6-EC35-4C44-92E3-C5481FD43E84Q44678992-E9B7B1DB-E8B7-4DE1-BC23-A4F1AE83F379Q44758611-495E4BC7-3C34-4A73-B98F-B0CCC33336B0Q45106395-3003F8C2-599F-4316-824A-8BF8D4560337Q45273098-6F776E3B-46A9-428B-98E5-6F84BB617337Q46689842-B4D4FB26-B1C1-469B-A3B7-A58D5F9C8A36Q46720103-8CA8181B-6114-483E-9023-0F0F152BF635Q47111293-ACBC8E11-7ACC-4CFD-AD75-33D46C4B5253Q47423382-2441417F-7F4A-4553-AAE0-EC434482FCEF
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Annette H. van der Helm-van Mil
@en
van der Helm-van Mil AH
@ast
van der Helm-van Mil AH
@es
van der Helm-van Mil AH
@nl
type
label
Annette H. van der Helm-van Mil
@en
van der Helm-van Mil AH
@ast
van der Helm-van Mil AH
@es
van der Helm-van Mil AH
@nl
prefLabel
Annette H. van der Helm-van Mil
@en
van der Helm-van Mil AH
@ast
van der Helm-van Mil AH
@es
van der Helm-van Mil AH
@nl
P106
P31
P496
0000-0001-8572-1437